www.fdanews.com/articles/74048-eli-lilly-licenses-taisho-diabetes-drug
ELI LILLY LICENSES TAISHO DIABETES DRUG
July 7, 2005
Drug maker Eli Lilly said Wednesday that it signed a licensing agreement with Japanese drug maker Taisho Pharmaceutical to eventually market a novel Type 2 diabetes treatment currently in development. Under the agreement, Lilly gets exclusive rights to develop and market Taisho's TS-021, a diabetes treatment that inhibits an enzyme responsible for breaking down a hormone crucial to maintaining blood sugar levels.
Forbes (http://www.forbes.com/business/energy/feeds/ap/2005/07/06/ap2125116.html)